CLB · Categories · Form 4

CLB - SEC Form 4 insider transactions

Core Laboratories Inc. (CLB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CLB

• 34d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 97 shares and converted options into 250 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 61d
  SEC Form 4 filed by Murray Katherine

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 61d
  SEC Form 4 filed by Anastasio Curt

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 61d
  SEC Form 4 filed by Klingensmith Harvey Robert

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 61d
  SEC Form 4 filed by Temeng Kwaku

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 61d
  SEC Form 4 filed by Martinovich Robert F

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 61d
  SEC Form 4 filed by Carnes Martha Z.

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 111d
  SEC Form 4 filed by SVP, Gen Counsel & Secretary Tattoli Mark Damian

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 111d
  SEC Form 4 filed by SVP Gresham Gwendolyn

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 111d
  SEC Form 4 filed by SVP & CFO Hill Christopher Scott

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 111d
  SEC Form 4 filed by Chairman and CEO Bruno Lawrence

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 111d
  SEC Form 4 filed by CAO & Treasurer Teo Sow Hang

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 153d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 14,310 shares and converted options into 24,952 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 153d
  SVP Gresham Gwendolyn covered exercise/tax liability with 19,301 shares and converted options into 24,952 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 153d
  SVP & CFO Hill Christopher Scott covered exercise/tax liability with 32,152 shares and converted options into 61,417 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 153d
  Chairman and CEO Bruno Lawrence converted options into 180,722 shares and covered exercise/tax liability with 112,681 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 187d
  CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 340 shares and converted options into 864 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 248d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 276 shares and converted options into 700 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 248d
  CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 99 shares and converted options into 250 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 307d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian converted options into 250 shares and covered exercise/tax liability with 99 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 307d
  CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 198 shares and converted options into 440 shares, decreasing direct ownership by 1% to 7,748 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 398d
  CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 79 shares and converted options into 175 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 398d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 1% to 16,072 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 431d
  Director Temeng Kwaku converted options into 9,317 shares, increasing direct ownership by 57% to 25,528 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 431d
  Director Murray Katherine converted options into 9,317 shares, increasing direct ownership by 78% to 21,221 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 431d
  Director Klingensmith Harvey Robert converted options into 9,317 shares, increasing direct ownership by 29% to 41,962 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 431d
  Director Carnes Martha Z. converted options into 9,317 shares, increasing direct ownership by 25% to 46,328 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 431d
  Director Anastasio Curt converted options into 9,317 shares, increasing direct ownership by 145% to 15,736 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 431d
  Director Straughen Michael covered exercise/tax liability with 4,634 shares and converted options into 9,317 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 479d
  SEC Form 4 filed by CAO & Treasurer Teo Sow Hang

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 479d
  SEC Form 4 filed by SVP, Gen Counsel & Secretary Tattoli Mark Damian

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 479d
  SEC Form 4 filed by SVP Gresham Gwendolyn

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 479d
  SEC Form 4 filed by SVP & CFO Hill Christopher Scott

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 479d
  SEC Form 4 filed by Chairman and CEO Bruno Lawrence

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 520d
  Chairman and CEO Bruno Lawrence covered exercise/tax liability with 43,380 shares and converted options into 69,574 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 520d
  SVP & CFO Hill Christopher Scott covered exercise/tax liability with 14,719 shares and converted options into 23,607 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 520d
  SVP Gresham Gwendolyn covered exercise/tax liability with 5,989 shares and converted options into 9,604 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 520d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 5,028 shares and converted options into 9,604 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 552d
  CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 227 shares and converted options into 576 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 612d
  CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 99 shares and converted options into 250 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 612d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian converted options into 700 shares and covered exercise/tax liability with 276 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 671d
  SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 147 shares and converted options into 370 shares, decreasing direct ownership by 2% to 10,769 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 671d
  CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 218 shares and converted options into 520 shares, decreasing direct ownership by 4% to 6,690 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 766d
  Teo Sow Hang covered exercise/tax liability with 79 shares and converted options into 175 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 766d
  Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 2% to 10,577 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 787d
  SEC Form 4 filed by Teo Sow Hang

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 796d
  Temeng Kwaku converted options into 6,419 shares, increasing direct ownership by 66% to 16,211 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 796d
  Straughen Michael covered exercise/tax liability with 3,017 shares and converted options into 6,419 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 796d
  Murray Katherine converted options into 6,419 shares, increasing direct ownership by 117% to 11,904 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 796d
  Klingensmith Harvey Robert converted options into 6,419 shares, increasing direct ownership by 24% to 32,645 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 796d
  Carnes Martha Z. converted options into 6,419 shares, increasing direct ownership by 21% to 37,011 units (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 796d
  Anastasio Curt converted options into 6,419 shares (SEC Form 4)

  4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
• 1161d
  SEC Form 4 filed by Van Dijken Eeuwijk Monique

  4 - CORE LABORATORIES N V (0001000229) (Issuer)
• 1161d
  SEC Form 4 filed by Temeng Kwaku

  4 - CORE LABORATORIES N V (0001000229) (Issuer)
• 1161d
  SEC Form 4 filed by Straughen Michael

  4 - CORE LABORATORIES N V (0001000229) (Issuer)
• 1161d
  SEC Form 4 filed by Murray Katherine

  4 - CORE LABORATORIES N V (0001000229) (Issuer)
• 1161d
  SEC Form 4 filed by Klingensmith Harvey Robert

  4 - CORE LABORATORIES N V (0001000229) (Issuer)
• 1161d
  SEC Form 4 filed by Carnes Martha Z.

  4 - CORE LABORATORIES N V (0001000229) (Issuer)
• 1202d
  SEC Form 4 filed by Tattoli Mark Damian

  4 - CORE LABORATORIES N V (0001000229) (Issuer)
• 1202d
  SEC Form 4 filed by Hill Christopher Scott

  4 - CORE LABORATORIES N V (0001000229) (Issuer)

Other CLB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends